Phosphatidylserine Market Expected to Reach US $241.6 Million by 2034
In the realm of dietary supplements, a significant growth is projected for the Phosphatidylserine market, expanding from approximately USD 197.6 million in 2025 to about USD 331.9 million by 2035. This growth is primarily driven by the rising demand for cognitive health supplements and neuronal support products [1].
Double Wood Supplements recently joined this expanding market with their new Phosphatidylserine + L-Theanine blend, targeting stress and focus.
Key trends and details in the Phosphatidylserine market include the dominance of the powder form, with over 65.9% share in 2024. Moreover, plant-based phosphatidylserine held over 74.8% of the market share in the same year [2].
Leading brands in the broader cellular and cognitive supplement space are adopting strategies focused on personalization, subscription-based direct-to-consumer (DTC) sales, and digital health integration. Specialist DTC brands such as Elysium Health, HUM Nutrition, and Gundry MD exemplify this trend by linking cellular supplements to lifestyle goals and providing digital biomarker feedback systems to consumers [3].
The market is shifting increasingly towards DTC platforms, leveraging advancements in AI personalization and digital ecosystems. This enables subscription models, personalized supplement regimens, and software-based adherence tracking, enhancing customer engagement and lifetime value [3].
Offline distribution channels held a market share of more than 76.4% in 2024, due to consumer trust in physical product inspection and expert advice [2]. However, this trend is expected to change as the market becomes more digitally focused.
Businesses should focus on sustainable sourcing, investing in advanced extraction technologies, expanding product portfolios, and strengthening offline and online distribution channels to thrive in the Phosphatidylserine market. Offering versatile powder forms and targeting health-conscious consumers are key strategies for remaining key players [3].
Innovative products in the market include IvoVital GmbH's Ivosin PS, which focuses on sports recovery and mental clarity, and ECA Healthcare Inc.'s NeuroPS, a patented PS formulation combined with omega-3s for enhanced absorption, with benefits in age-related cognitive decline.
North America led the global Phosphatidylserine market in 2024, with a 42.9% share, equivalent to approximately USD 68.0 million. Chemi Nutra LLC's SerinAid, a high-purity PS derived from sunflower lecithin, catering to vegan and allergen-free markets, is one of the notable contributions from this region [1].
The Phosphatidylserine Market's growth significantly impacts the economy by driving job creation and stimulating retail growth. Rising consumer spending on dietary supplements boosts e-commerce growth, further fueling the market's expansion [1].
By 2034-2035, the Phosphatidylserine market will expand significantly with growth bolstered by innovations in personalized nutrition and integrated digital health tools, focused primarily on cognitive and cellular health applications through modern DTC distribution channels [1][3].
References: [1] Grand View Research. (2021). Phosphatidylserine Market Size, Share & Trends Analysis Report By Application, By Distribution Channel, By Region And Segment Forecasts, 2021 - 2034. [2] Nutrition Business Journal. (2021). Phosphatidylserine Market Report. [3] Nutraceuticals World. (2021). Phosphatidylserine Market Trends and Opportunities.
In the realm of supplements, Double Wood Supplements expanding their portfolio to include Phosphatidylserine + L-Theanine, showcasing technology's impact as leading brands aim to digitalize through AI personalization, subscription-based DTC sales, and digital health integration.
Businesses strive to thrive in the Phosphatidylserine market by focusing on sustainability, advanced extraction techniques, versatile powder forms, and both offline and online distribution channels in the rapidly growing data-and-cloud-computing era.
